Growth Metrics

Whitehawk Therapeutics (WHWK) Invested Capital (2010 - 2026)

Whitehawk Therapeutics (WHWK) reported Invested Capital of $116.2 million for Q1 2026, down 47.6% year-over-year from $221.7 million in Q1 2025, and down 14.77% on a QoQ basis from $136.3 million in Q4 2025.

Whitehawk Therapeutics (WHWK) has 17 years of Invested Capital data on file, last reported at $116.2 million in Q1 2026.

  • Quarterly Invested Capital fell 47.6% year-over-year to $116.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $116.2 million (down 47.6% YoY) and the FY2025 annual result came in at $136.3 million, up 159.75% from the prior year.
  • Invested Capital fell to $116.2 million in Q1 2026 per WHWK's latest filing, from $136.3 million in the prior quarter.
  • Across five years, Invested Capital topped out at $221.7 million in Q1 2025 and bottomed at $52.5 million in Q4 2024.
  • The 5-year median for Invested Capital is $124.6 million (2022), against an average of $126.8 million.
  • The widest annual swing landed in 2022, when Invested Capital soared 797.34%; it then slumped 50.11% in 2024.
  • Tracing WHWK's Invested Capital over 5 years: stood at $158.4 million in 2022, then slumped by 33.58% to $105.2 million in 2023, then tumbled by 50.11% to $52.5 million in 2024, then jumped by 159.75% to $136.3 million in 2025, then slipped by 14.77% to $116.2 million in 2026.
  • Per Business Quant, the three latest WHWK Invested Capital figures stand at $116.2 million (Q1 2026), $136.3 million (Q4 2025), and $157.2 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 595,226.00
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 110.96 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 14.38 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 19.36 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 31.42 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 1.08 Bn
10 Whitehawk Therapeutics 312.26 Mn 189.22 Mn - 116.18 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 116.18 Mn
Dec 31, 2025 136.31 Mn
Sep 30, 2025 157.17 Mn
Jun 30, 2025 172.07 Mn
Mar 31, 2025 221.73 Mn
Dec 31, 2024 52.48 Mn
Sep 30, 2024 68.87 Mn
Jun 30, 2024 78.79 Mn
Mar 31, 2024 90.46 Mn
Dec 31, 2023 105.20 Mn
Sep 30, 2023 118.20 Mn
Jun 30, 2023 131.42 Mn
Mar 31, 2023 145.99 Mn
Dec 31, 2022 158.38 Mn
Sep 30, 2022 169.11 Mn
Jun 30, 2022 108.73 Mn
Mar 31, 2022 124.63 Mn
Dec 31, 2021 136.66 Mn
Sep 30, 2021 150.95 Mn
Jun 30, 2021 -19.37 Mn
Mar 31, 2021 -17.87 Mn
Dec 31, 2020 1.88 Mn
Sep 30, 2020 -20.49 Mn
Jun 30, 2020 -17.63 Mn
Mar 31, 2020 -12.39 Mn
Dec 31, 2019 -9.09 Mn
Sep 30, 2019 41.71 Mn
Jun 30, 2019 45.72 Mn
Mar 31, 2019 50.80 Mn
Dec 31, 2018 58.67 Mn
Sep 30, 2018 66.52 Mn
Jun 30, 2018 47.91 Mn
Mar 31, 2018 11.11 Mn
Dec 31, 2017 17.44 Mn
Sep 30, 2017 23.42 Mn
Jun 30, 2017 27.94 Mn
Mar 31, 2017 33.31 Mn
Dec 31, 2016 -86.22 Mn
Sep 30, 2016 -207,257.00
Jun 30, 2016 -200,483.00
Mar 31, 2016 -192,837.00
Dec 31, 2015 -66.55 Mn
Sep 30, 2015 -174,649.00
Jun 30, 2015 -168,128.00
Mar 31, 2015 -160,856.00
Dec 31, 2014 -155,041.00
Sep 30, 2014 -143,388.00
Jun 30, 2014 -136,960.00
Mar 31, 2014 -130,008.00
Dec 31, 2013 -124,242.00
Sep 30, 2013 -114,492.00
Jun 30, 2013 -108,353.00
Mar 31, 2013 -101,604.00
Dec 31, 2012 -95,541.00
Sep 30, 2012 -85,879.00
Jun 30, 2012 -79,841.00
Mar 31, 2012 -73,538.00
Dec 31, 2011 -68,176.00
Sep 30, 2011 -59,242.00
Jun 30, 2011 -52,905.00
Dec 31, 2010 -40,991.00